ALRN Archived Articles
Aileron Therapeutics (ALRN): Navigating the Frontiers of Orphan Pulmonary and Fibrosis Treatments
Published on November 30, 2024
Aileron Therapeutics, Inc. (NASDAQ:ALRN): Shifting Focus to Orphan Pulmonary and Fibrosis Indications
Published on September 24, 2024